• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Al-Azhar Dental Journal for Girls
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 8 (2021)
Volume Volume 7 (2020)
Volume Volume 6 (2019)
Volume Volume 5 (2018)
Issue Issue 4
Issue Supplement
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2017)
Volume Volume 3 (2016)
Abdel Rahman, N., Al Shal, O., Shaker, O., Shafik, M. (2018). Evaluation of Subantimicrobial Dose Doxycycline Effects on Dental Implant Osseointegration in Type II Diabetic Patients. Al-Azhar Dental Journal for Girls, 5(3), 225-235. doi: 10.21608/adjg.2018.17152
Nora Abdel Rahman; Ossama Al Shal; Olfat Shaker; Mai Shafik. "Evaluation of Subantimicrobial Dose Doxycycline Effects on Dental Implant Osseointegration in Type II Diabetic Patients". Al-Azhar Dental Journal for Girls, 5, 3, 2018, 225-235. doi: 10.21608/adjg.2018.17152
Abdel Rahman, N., Al Shal, O., Shaker, O., Shafik, M. (2018). 'Evaluation of Subantimicrobial Dose Doxycycline Effects on Dental Implant Osseointegration in Type II Diabetic Patients', Al-Azhar Dental Journal for Girls, 5(3), pp. 225-235. doi: 10.21608/adjg.2018.17152
Abdel Rahman, N., Al Shal, O., Shaker, O., Shafik, M. Evaluation of Subantimicrobial Dose Doxycycline Effects on Dental Implant Osseointegration in Type II Diabetic Patients. Al-Azhar Dental Journal for Girls, 2018; 5(3): 225-235. doi: 10.21608/adjg.2018.17152

Evaluation of Subantimicrobial Dose Doxycycline Effects on Dental Implant Osseointegration in Type II Diabetic Patients

Article 2, Volume 5, Issue 3, Summer 2018, Page 225-235  XML PDF (257.87 K)
Document Type: Original Article
DOI: 10.21608/adjg.2018.17152
Authors
Nora Abdel Rahman1; Ossama Al Shal2; Olfat Shaker3; Mai Shafik4
1Associate Lecturer of Oral Medicine, Periodontology, Oral diagnosis and Radiology Department. Faculty of Dental Medicine for Girls. Al-Azhar University.
2Professor of Oral Medicine, Periodontology, Oral diagnosis and Radiology Department, Vice- Dean for Postgraduate Studies. Faculty of Dental Medicine for Girls. Al-Azhar University.
3Professor of Bio-Chemistry. Faculty of Medicine. Cairo University.
4Associate Professor of Oral Medicine, Periodontology, Oral diagnosis and Radiology, Department. Faculty of Dental Medicine for Girls. Al-Azhar University.
Abstract
Objective
: The present study was carried out to compare radiographic outcomes of dental implant in type II diabetic patients with or without adjunctive administration of subantimicrobial dose doxycycline.
 
Subjects and Methods : This study included 20 patients with controlled type II diabetes mellitus of both genders, their age ranged from 40-48years.The study groups were designed in two groups, test group treated with dental implant with systemic administration of subantimicrobial dose doxycycline(SDD) for twice per day for 3 months and control group received dental implant alone.
 
Results: Regarding radiographic marginal bone levels measurements; in both groups the mean marginal bone loss increased by time, with significant difference between both groups where the test group (SDD received group) showed the lower marginal bone loss values. In both groups, bone density measurements increased by time, with significant percentage change recorded for test group (SDD received group) 55.22% while control group recorded 17.40% from base line values.
Conclusions:
The use of sub-antimicrobial dose doxycycline with dental implants in type II diabetic patients was effective as an adjunctive host modulatory drug. Systemic administration of subantimicrobial dose doxycycline with dental implants in type II diabetic patients resulted in greater increase in bone density and less marginal bone loss thus subantimicrobial dose doxycycline can enhance the osseointegration of dental implants.
Keywords
Diabetes mellitus; Subantimicrobial dose doxycycline; dental implant; Cone beam computed tomography
Main Subjects
Oral Medicine and Periodontology
References

1. Javed F, Romanos GE. Impact of diabetes mellitus and

glycemic control on the osseointegration of dental implants:

a systematic literature review. J Periodontol. 2009;

80:1719–1730.

2. Preeti AK, Manish K. Rupal J. Shah. Rehabilitative

Considerations for Dental Implantsin the Diabetic Patient.

J Indian Prostho dont Soc 13:175–183.

3. Preshaw PM. Host response modulation in periodontics.

Periodontology 2000. 2008; 48: 92-110.

4. Isoda K, Ayukawa Y, Tsukiyama Y, Sogo M, Matsushita

Y, Koyano K. Relationship between the bone densities estimated

by cone-beam computed tomography and the primary

stability of dental implants. Clin Oral Implants Res

2012; 23:832-836.

5. González-Martín O, Lee EA, Veltri M: CBCT fractal dimension

changes at the apex of immediate implants placed

using undersized drilling. Clin. Oral Implants Res 2012;

23: 954–95.

6. Hsu JT, Chang HW, Huang HL, Yu JH, Li YF, Tu MG:

Bone density changes around teeth during orthodontic

treatment. Clin Oral Investig 2011; 15:511-519

7.

 

Monje A, Monje F, Gonzalez-Garcı R, GalindoMoreno P,

Rodriguez-Salvanes F, Wang HL. Comparison between

microcomputed tomography and cone-beam computed

tomography radiologic bone to assess atrophic posterior

maxilla density and microarchitecture. Clin Oral Implants

Res 2014; 25: 723-728.

8. Hasan I, Dominiak M, Blaszczyszyn A, Bourauel C,

Gedrange T, Heinemann F. Radiographic evaluation of

bone density around immediately loaded implants. Ann

Anat 2015; 199:52-57.

9. Kholsa S. Minireview: the Opg/Rankl/Rank system.

Endocrinology 2001; 142: 5050–5055.

10. Abramson, J. H. The Cornell medical index as an epidemiological

tool, Am J Pub H and the Nat H 1966; 56:

287–298.

11. Caton J, Ryan ME. Clinical studies on the management of

periodontal diseases utilizing subantimicrobial dose doxycycline

(SDD). Pharmacol Res .2011; 63: 114-120.

12. Busenlechner D, Furhauser R, Haas R, Watzek G, Mailath

G, Pommer B. Long-term implant success at the Academy

for Oral Implantology: 8-year follow-up and risk factor

analysis. J Periodontal Implant Sci 2014; 44:102–8.

13.

 

Lambert P, Morris H, Ochi S: The influence of 0.12%

chlorhexidine digluconate rinses on the incidence of infectious

complications and implant success. J Oral Maxillofac

Surg 1997; 55:25-30.

14. Yassir Elkhidir, Sun Wei, Li Suyang, Mengqing Xie and

Cheng Yang. Feasibility of CBCT in Evaluating Bone

Density of Dental Implant Placement Sites. RRJDS. 2017;

5:87-91

15

Schwartz A. Diabetes mellitus: does it affect bone? CTI

2003; 73:515-9.

16. Oates T, Huynh-Ba G, Vargas A, Alexander P, Feine J. A

critical review of diabetes, glycemic control, and dental

implant therapy. Clin Oral Implants Res 2013; 24:117-27.

17. Olson JW, Shernoff AF, Tarlow JL, Colwell JA, Scheetz

JP, Bingham SF. Dental endosseous implant assessments

in a type 2 diabetic population: A prospective study. Int J

Oral Maxillofac Implants 2000; 15:811-818.

18. Peled M, Ardekian L, Tagger-Green N, Gutmacher Z,

Machtei EE. Dental implants in patients with type 2

diabetes mellitus: A clinical study. Implant Dent 2003;

12:116-122.

19. Casap N, Nimri S, Ziv E, Sela J, Samuni Y. Type 2 diabetes

has minimal effect on osseointegration of titanium

implants in Psammomys obesus. Clin Oral Implants Res

2008; 19:458-64.

20.

 

Balshi SF, Wolfinger GJ, Balshi TJ. An examination of

immediately loaded dental implant stability in the diabetic

patient using resonance frequency analysis (RFA).

Quintessence Int 2007; 38:271-9.

21. Tawil G, Younan R, Azar P, Sleilati G. Conventional and

advanced implant treatment in the type II diabetic patient:

surgical protocol and long-term clinical results. Int J Oral

Maxillofac Implants 2008; 23:744–52.

22. Morris HF, Ochi S, Winkler S. Implant survival in patients

with type 2 diabetes. Ann Periodontol 2000; 5:157-65.

23. Mccracken MS, Aponte-Wesson R, Chavali R, Lemons

JE McCracken. Bone associated with implants in diabetic

and insulin-treated rats. Clin Oral Implants Res 2006; 17:

495-500.

24. Hasegawa H, Ozawa S, Hashimoto K, Takeichi T, Ogawa T.

Type 2 diabetes impairs implant osseointegration capacity

in rats. Int J Oral Maxillofac Implants 2008; 23:237-246.

25. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host

modulation with antiproteinase, anti- inflammatory, and

bone-sparing agents. A systematic review. Ann Periodontol

2003; 8:12-37.

26. Preshaw PM, Hefti AF, Novak MJ. Subantimicrobial

dose doxycycline enhances the efficacy of scaling and

root planing in chronic periodontitis: a multicenter trial. J

Periodontol 2004;75:1068-76.

27. Khoury SB, Thomas L, Walters JD, Sheridan JF,

Leblebicioglu B. Early wound healing following one-stage

dental implant placement with and without antibiotic prophylaxis:

a pilot study. J Periodontol 2008; 79:1904–1912.

28. Alissa R, Sakka S, Oliver R, Horner K, Esposito M,

Worthington HV, Coulthard P. Influence of ibuprofen

on bone healing around dental implants: a randomized

double-blind placebo controlled clinical study. Eur J Oral

Implantol 2009; 2:185–199.

29. Waasdorp JA, Evian CI, Mandracchia M. Immediate

placement of implants into infected sites: a systematic

review of the literature. J. Periodontol 2010; 81:801–806.

30.

 

Barunawarty Y. Assessment of the increased calcification

of jaw bone with CT-Scan after dental implant placement.

Imaging Sci Dent 2011; 41: 59- 62.

31. Golub L, Lee H-M, Greenwald R, Ryan M, Sorsa T, Salo

T. A matrix metalloproteinase inhibitor reduces bone-type

collagen degradation fragments and specific collagenases

in gingival crevicular fluid during adult periodontitis. IR

1997; 46:310-9.

32. Gomes PS, Fernandes MH. Effect of therapeutic levels

of doxycycline and minocycline in the proliferation and

differentiation of human bone marrow osteoblastic cells.

AOB 2007; 52:251-9.

33. Almazin SM, Dziak R, Andreana S. The effect of

doxycycline hyclate, chlorhexidine gluconate, and

minocycline hydrochloride on osteoblastic proliferation

and differentiation in vitro. J Periodontol 2009; 80: 999–

1005.

34. Eglence A, Colterjohn N, Duivenvoorden WC, Ghert M,

Singh G. Effect of bone morphogenetic protein-2 and

doxycycline on the differentiation of osteoprogenitors

from human femoral bone. Open Bone J. 2009; 1:1-7.

35. Shahabooei M, Razavi SM, Minaiyan M. A

histomorphometric study of the effect of doxycycline and

erythromycin on bone formation in dental alveolar socket

of rat. Adv Biomed Res 2015; 4:71.

36. Lin Ding, Peng Zhang, Xin Wang, Jia Hao, Kazuhiro Aoki,

Shinji Kuroda, Shohei Kasugai Effect of doxycyclinetreated

hydroxyapatite surface on bone apposition: A

histomophometric study in murine maxillae. DMJ 2017;

11: 1- 9.

37. Yiming Liu, Jing Hu, Biao Liu, Xiliang Jiang, Yunfeng

Li. peri-implant bone mass and improved trabecular

microarchitecture. The effect of osteoprotegerin on

implant osseointegration in ovariectomized rats. Arch Med

Sci 2017; 13, 2: 489–495.

38. Sunitha RV, Ramakrishnan T, Kumar S, Emmadi P. Soft

tissue preservation and crestal bone loss around singletooth

implants. J Oral Implantol 2008; 34:223-229.

39. PriyanKa Boora, Manu rathee, MohaneeSh Bhoria. Effect

of Platelet Rich Fibrin on Peri- implant Soft Tissue and

Crestal Bone. JCDR 2015; 9: 18-21.

40. Cavallaro JS Jr. Implant survival and radiographic analysis

of proximal bone levels surrounding a contemporary

dental implant. Implant Dent 2011; 20: 146-5.

41. Lee DW, Choi YS, Park KH, Kim CS, Moon IS. Effect of

microthread on the maintenance of marginal bone level:

a 3-year prospective study. Clin Oral Implants Res 2007;

18:465-70.

42. Cochran DL, Nummikoski V, Schoolfeld JD, Jones AA,

Oates TW. A prospective multicenter 5-year radiographic

evaluation of crestal bone levels over time in 596 dental

implants placed in 192 patients. J Periodontol 2009;

80:725-33.

43. Choi DH, Moon IS. Effects of sub-antimicrobial dose

doxycycline therapy on crevicular fluid MMP-8 and

gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic

periodontitis. J Periodont Res 2004; 39: 20-26.

44. Kinugawa S, Koide M, Kobayashi Y. Tetracyclines convert

the osteoclasticdifferentiation pathway of progenitor cells

to produce dendritic cell-like cells. J Immunol 2012; 188:

1772–1781.

45. Nurdan O, Ceren G. Chemical inhibition of matrix

metalloproteinases for periodontal treatment. Antiinflamm

Antiallergy Agents Med Chem 2015; 2: 21-26.

46. Bezerra MM, Brito GA, Ribeiro RA. Low-dose

doxycycline prevents inflammatory bone resorption in

rats. Braz J Med Biol Res 2002; 35: 613–616.

47. Holmes SG, Still K, Buttle DJ, Bishop NJ. Chemically

modified tetracyclines act through multiple mechanisms

directly on osteoclast precursors. Bone 2004; 35:471-8.

48. Zhang C, Tang TT, Ren WP. Inhibiting wear particlesinduced

osteolysis with doxycycline. Acta Pharmacol Sin

2007; 28:1603–1610.

.

Statistics
Article View: 194
PDF Download: 187
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.